Delivery Order SPE2DB20D1100-SPE2DB25FC0Z9

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg medication. The delivery order, valued at $3,465.90, is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a total ceiling value of $7,904.77 and a period of performance through August 2, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a ceiling value of $3,406.81 and an ultimate completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg dosage syringes. The contract has a firm fixed price of $8,067.80 and a performance period that runs through August 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,585,932 units of Cosentyx (secukinumab), a specialty medication. The delivery order, valued at $7,609.75, has a firm fixed price and no set-aside designation. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Cosentyx (secukinumab) in 300 mg doses. The ceiling value of the contract is $9,131.72, and it has a completion date of July 25, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will be responsible for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract is for the supply of Cosentyx (secukinumab) 300 mg doses in pre-filled syringes, with a total ceiling value of $10,049.44 and a completion date of February 10, 2025. The contract is a firm-fixed-price delivery order, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx 300mg dose injections. The award, valued at $3,486.10, is a firm fixed-price contract with a completion date of January 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Cosentyx (secukinumab) 300 mg injection. The total ceiling value of this order is $3,149.12, with a period of performance ending on March 26, 2025. This award is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx 300 mg dose-2 syringes, a prescription medication. The award has a ceiling value of $51,331.58 and a period of performance through April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC0Z9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg/2 mL injections. The contract has a ceiling value of $7,820.90 and a period of performance through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp, as the prime contractor, will be responsible for supplying the required pharmaceutical product to support federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/3/25, 1:22 AM